Clinical Trials Browser

Phase 1 × Active not recruiting × Unspecified Adult Solid Tumor, Protocol Specific × Clear all

NCT02112565 2025-07-04

RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists

Phase 1 Active not recruiting

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific